GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Parabilis Medicines, Inc. Common Stock PBLS · USD

US listing · 🇺🇸 United States

Compare

27.44

-0.69%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Parabilis Medicines, Inc. Common Stock — daily PBLS Delayed
Market value
$3.31bn
Last close × shares
Volume
1.2m
Shares, 20 Nov 2026

About Parabilis Medicines, Inc. Common Stock

Its shares trade under the ticker PBLS. It has been listed since 10 June 2026.

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Figures and description from our data supplier, not checked against the company's own report.

More about Parabilis Medicines, Inc. Common Stock →

Latest on Parabilis Medicines, Inc. Common Stock

Our reporting

Next results

11 Feb 2027

Due on 11 Feb 2027. Analysts expect earnings of -0.45 a share.

Other United States listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Parabilis Medicines, Inc. Common Stock's ticker?

Parabilis Medicines, Inc. Common Stock trades as PBLS on its US listing, under ISIN US6989551014.

What was Parabilis Medicines, Inc. Common Stock's last closing price?

27.44 on 20 Nov 2026. The figure is in USD and is never converted.

When does Parabilis Medicines, Inc. Common Stock next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.